Prevalence of Hiv Seroreactivity in Anogenital Wart Patients at ALERT, Addis Ababa, Ethiopia: A Prospective Study
| dc.contributor.advisor | Selamawit Girma | |
| dc.contributor.author | Petros Habtamu | |
| dc.date.accessioned | 2025-08-07T06:40:43Z | |
| dc.date.available | 2025-08-07T06:40:43Z | |
| dc.date.issued | 2024-12-05 | |
| dc.description.abstract | Anogenital warts (AGWs) are visible warts seen in the body's perigenital and perianal regions(1). They are benign lesions caused by HPV types 6 or 11 which are low risk (LR) types, with the remaining 10% caused by a co-infection with high risk (HR) types(1–3). In addition to epidemiological evidence, biological findings confirm the mechanisms for sexually transmitted infections (STIs) increasing Human Immunodeficiency Virus (HIV) acquisition and transmission via direct mucosal disruption, recruitment of HIV target cells to the genital tract, and increased HIV load in plasma and genital secretions(8). Immunosuppression, on the other hand, is a key risk factor for chronic human papilloma virus (HPV) infections and, as a result, the development of HPV-induced lesions. The frequency and prevalence of benign and malignant HPV-induced anogenital lesions are much higher in HIV-infected patients | |
| dc.identifier.uri | https://etd.aau.edu.et/handle/123456789/6177 | |
| dc.language.iso | en_US | |
| dc.publisher | Addis Ababa University | |
| dc.subject | Prevalence of HIV Seroreactivity | |
| dc.title | Prevalence of Hiv Seroreactivity in Anogenital Wart Patients at ALERT, Addis Ababa, Ethiopia: A Prospective Study | |
| dc.type | Thesis |